Considering the nature of HMGB1 as a cytokine and the paracrine model by which CAFs might drive the progression of breast cancer, we further demonstrated that activation of GPR30 in CAFs induced resistance to TAM in MCF-7 cells through the paracrine action of HMGB1. This evidence concerns the gene GPER1 and breast carcinoma.